These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10083119)

  • 1. Kidney graft-infiltrating cells synthesize significantly higher amounts of prostaglandin E2 pre and during acute rejection.
    Pestana M; Oliveira G; Xavier P; Mendes A; Guerra LE
    Transplant Proc; 1999; 31(1-2):306-7. PubMed ID: 10083119
    [No Abstract]   [Full Text] [Related]  

  • 2. P-glycoprotein expression in acute kidney graft rejection.
    Vergara E; Gómez-Morales M; Ramírez C; Osuna A; Olmo A; O'Valle F; Sáez AI; Alvarez G; Palomares M; Aguilar M; Bravo J; Asensio C; Del Moral RG
    Transplant Proc; 1998 Aug; 30(5):2425-6. PubMed ID: 9723524
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary prostanoids excretion in kidney transplantation: its relationship to acute rejection and cyclosporine-induced nephrotoxicity.
    Oppenheimer F; Hotter G; Bulbena O; Roselló-Catafau J; Gelpí E; Vilardell J; Ricart MJ; Campistol JM; Fernández-Cruz L; Carretero P
    Transplant Proc; 1994 Oct; 26(5):2606-7. PubMed ID: 7940811
    [No Abstract]   [Full Text] [Related]  

  • 4. The status of B2 receptors in acute renal transplant rejection.
    Naidoo S; Ramsaroop R; Naidoo Y; Bhoola KD
    Immunopharmacology; 1996 Jun; 33(1-3):157-60. PubMed ID: 8856138
    [No Abstract]   [Full Text] [Related]  

  • 5. Weekly protocol renal transplant biopsies allow detection of sub-clinical acute rejection episodes in patients with delayed graft function.
    Jain S; Curwood V; White SA; Williams ST; Doughman T; Nicholson ML
    Transplant Proc; 2000 Feb; 32(1):191. PubMed ID: 10701020
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical correlation of acute rejection according to Banff classification in renal transplantation.
    Lorriaux C; Pouteil Noble C; Dijoud F; Cahen R; Touraine JL; MacGregor B
    Transplant Proc; 2000 Mar; 32(2):443-4. PubMed ID: 10715473
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute rejection is a major risk factor for chronic rejection.
    Matas AJ
    Transplant Proc; 1998 Aug; 30(5):1766-8. PubMed ID: 9723273
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection.
    Wiener Y; Nakhleh RE; Kupin WL; Lee M; Escobar FS; Venkat KK; Mozes MF
    Transplant Proc; 1995 Feb; 27(1):1014-5. PubMed ID: 7878781
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical validity of Banff grading of chronic rejection in renal transplantation.
    Oh CK; Jeong HJ; Kim YS; Kim MS; Choi KH; Lee HY; Han DS; Park K
    Transplant Proc; 1996 Jun; 28(3):1441-2. PubMed ID: 8658731
    [No Abstract]   [Full Text] [Related]  

  • 10. Multicenter trial of the therapeutic effect of a newly developed antiplatelet agent, satigrel, on biopsy-proven chronic rejection after kidney transplantation.
    Teraoka S; Ota K; Tanabe K; Takahashi K; Toma H; Yasumura T; Yoshimura N; Oka T; Takahara S; Okuyama A; Haba T; Uchida K; Sugiyama S; Ohshima S; Sato T; Okazaki H; Morozumi K
    Transplant Proc; 1997; 29(1-2):266-71. PubMed ID: 9122990
    [No Abstract]   [Full Text] [Related]  

  • 11. To biopsy or not to biopsy.
    Wigmore SJ; Forsythe JL
    Transplantation; 2003 Sep; 76(6):909-10. PubMed ID: 14531395
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrarenal display of cytotoxic attack molecules during rejection.
    Sharma VK; Bologa RM; Li B; Xu GP; Lagman M; Mouradian J; Wang J; Serur D; Rao VK; Suthanthiran M
    Transplant Proc; 1997; 29(1-2):1090-1. PubMed ID: 9123214
    [No Abstract]   [Full Text] [Related]  

  • 13. Proliferation rate of cells in the interstitial infiltrate in acute kidney allograft rejection.
    Olsen S; Hansen HE
    Transplant Proc; 1996 Feb; 28(1):502-3. PubMed ID: 8644329
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary thromboxane B2 and cyclic AMP in cyclosporine-A-treated kidney transplantation.
    Quereda C; Sabater J; Villafruela J; Revalderia JG; Marcen R; Ortuño J
    Transplant Proc; 1994 Oct; 26(5):2604-5. PubMed ID: 7940810
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of cytokines, growth factors, and adhesion molecules in rejecting human renal allograft.
    Loong CC; Chen A; Lui WY; King KL; Lin CY
    Transplant Proc; 1996 Jun; 28(3):1445-6. PubMed ID: 8658733
    [No Abstract]   [Full Text] [Related]  

  • 16. sTNFRI and sTNFRII synthesis by fine-needle aspiration biopsy sample cultures is significantly associated with acute rejection in kidney transplantation.
    Oliveira JG; Xavier P; Sampaio SM; Mendes AA; Pestana M
    Transplantation; 2001 Jun; 71(12):1835-9. PubMed ID: 11455266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute vascular rejection in renal transplantation.
    Salmela K; von Willebrand E; Kyllönen L; Eklund B; Höckerstedt K; Isoniemi H; Krogerus L; Taskinen E; Ahonen J
    Transplant Proc; 1992 Feb; 24(1):360-1. PubMed ID: 1539318
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro tests on macrophage prostaglandin E2 and thromboxane B2 production after blood transfusion.
    Ogle CK; Wood S; Nagy H; Palkert D; Carey M; Alexander JW
    Transplant Proc; 1988 Dec; 20(6):1179-83. PubMed ID: 3264428
    [No Abstract]   [Full Text] [Related]  

  • 19. Graft outcome in patients with biopsy-proven chronic renal allograft rejection.
    Peddi VR; Schroeder TJ; Weiskittel P; First MR
    Transplant Proc; 1999; 31(1-2):1308-9. PubMed ID: 10083584
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute rejection and the flow cytometry crossmatch.
    O'Malley KJ; Cook DJ; Roeske L; McCarthy JF; Klingman LL; Kapoor A; Hobart MG; Flechner SM; Modlin CS; Goldfarb DA; Novick AC
    Transplant Proc; 1999; 31(1-2):1216-7. PubMed ID: 10083543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.